Here are six things to know:
1. The Precision Medicine Alliance will provide patients with faster and more accurate diagnoses and treatments based on their genetic and molecular compositions.
2. About 150 hospitals and care centers across the nation will offer the precision medicine services to about 12 million patients every year.
3. The Precision Medicine Alliance will first zone in on advanced diagnostic tumor profiling in cancer treatment. The Alliance will also advance oncology research by populating a clinical cancer database.
4. Eventually, the Alliance will move onto cardiovascular risk and pharmacogenomics, as well.
5. Under the alliance, EMRs will be integrated into a data-management structure to offer quick access to correct clinical trial information.
6. By teaming up with laboratories and bioinformatics companies, the two health systems will create molecular tests tailored to meet individualized patient needs.
“Conventional wisdom suggests patients suffering from the same condition should be treated with the same therapy,” said Kevin E. Lofton, CEO, Catholic Health Initiatives. “Science now tells us that the efficacy of one-size fits all for medications and therapies varies by patient because each person has a unique DNA profile that responds differently to prevailing treatments.”
More articles on quality & infection control:
Antimicrobial resistance to take center stage at UN leader conference: 4 notes
Serial PCT testing in the fight against sepsis
Zika-exposed fetuses are 50 times more likely to develop microcephaly — 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
